Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 No DAC & Ipamorelin Muscle Growth Results: Protocol Comparison

100 mcg CJC / 100 mcg Ipa (nightly) 7×/week +0.8–1.2 kg +2.0–2.8 kg Moderate. Consider 5 days on, 2 days off after week 8 Maximizes pulsatile GH release but requires cycle breaks to prevent receptor downregulation 200 mcg CJC / 200 mcg Ipa (3×/week) 3×/week +0

This comparison does not assign a generated winner or score.

  • 100 mcg CJC / 100 mcg Ipa (nightly)
  • 7×/week
  • +0.8–1.2 kg
  • +2.0–2.8 kg
  • Moderate. Consider 5 days on, 2 days off after week 8
  • Maximizes pulsatile GH release but requires cycle breaks to prevent receptor downregulation
  • 200 mcg CJC / 200 mcg Ipa (3×/week)
  • 3×/week
  • +0.4–0.7 kg
  • +1.2–1.8 kg
  • Low. Intermittent dosing preserves receptor sensitivity
  • Lower total exposure but maintains natural GH pulsatility; ideal for long-term protocols
  • 100 mcg CJC / 200 mcg Ipa (5×/week)
  • 5×/week
  • +0.6–1.0 kg
  • +1.5–2.2 kg
  • Low-Moderate
  • Balanced approach. Weekend breaks reduce desensitization while sustaining IGF-1 elevation
  • Single peptide (CJC-1295 alone)
  • +0.3–0.5 kg
  • +0.8–1.3 kg
  • Low
  • GHRH analog without ghrelin mimetic produces lower peak GH amplitude; suboptimal for hypertrophy
More references

Related material

Comparison

CJC-1295 Ipamorelin vs HGH 2026

CJC-1295 Ipamorelin vs HGH 2026 Compare CJC-1295/Ipamorelin peptides to exogenous HGH: mechanisms, side effects, and published research data. CJC-1295 Ipamorelin vs HGH 2026. Comp…

View details →